Testing a new herbal patch for treating plantar fasciitis
Effect of a Novel Herbal Patch for the Treatment of Plantar Fasciitis - A Single-blind Randomized Controlled Trial
NA · Chinese University of Hong Kong · NCT05584046
This study is testing a new herbal patch to see if it can help people aged 18 to 65 with heel pain from plantar fasciitis feel better and improve their daily activities.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 24 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Chinese University of Hong Kong (other) |
| Locations | 1 site (Sha Tin) |
| Trial ID | NCT05584046 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of a novel herbal patch designed to alleviate symptoms of plantar fasciitis, a common and painful tendon overuse disorder. Participants aged 18 to 65 with heel pain lasting more than six weeks will be enrolled in a single-blind randomized controlled trial. The study aims to assess pain relief and functional improvement in patients using the herbal patch compared to a control. The trial will monitor outcomes using a visual analog scale (VAS) to measure pain levels.
Who should consider this trial
Good fit: Ideal candidates are males and females aged 18-65 experiencing unilateral or bilateral heel pain for over six weeks with a VAS score of 5 or higher.
Not a fit: Patients with chronic diseases affecting bone metabolism or those who have had recent knee surgeries or injuries may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could provide a non-invasive and effective option for patients suffering from plantar fasciitis.
How similar studies have performed: While there is limited data on herbal patches specifically for plantar fasciitis, other studies have shown promising results with alternative treatments for tendon injuries.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male and female with age 18-65 * Unilateral or bilateral * Heel pain for more than 6 weeks' duration * VAS score ≥ 5 * Signed informed consent. Exclusion Criteria: * Known chronic disease or receiving long-term medications affecting bone metabolism including BPs * Contraindication to alendronate therapy such as poor dental fitness * ACL injury less than 6 weeks * Injury on duty cases * Patients who have undergone arthroscopy or open surgery in the index knee in the last 12 months * Other associated injuries (fractures and other ligament involvement such as neurovascular bundles injury) * Chondral lesion with concomitant intervention * Presence of X-ray features of osteoarthritis including decrease in joint space, presence of osteophytes and subchondral cysts * Neurological deficit * Pregnant or breastfeeding * Inability to give informed consent
Where this trial is running
Sha Tin
- Prince of Wales Hospital — Sha Tin, Hong Kong (RECRUITING)
Study contacts
- Study coordinator: Patrick Shu-hang YUNG
- Email: patrickyung@cuhk.edu.hk
- Phone: +852 3505 2728
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Plantar Fasciitis, Herbal Patch